Daniel Thomas

A joint venture of Elliott and Morning Calm has acquired City Office REIT, a bold move signaling a contrarian belief in the office market's recovery.

Amid a massive wealth migration to the Sunshine State, Glenmede appoints Joe Coconate to lead its charge in the highly competitive UHNW market.

A new report reveals 10 proven ways to fix the critical mental health gap for trafficking survivors, as 75% call it their most urgent need.

With a key drug in late-stage trials and a bolstered team, Palvella Therapeutics aims to deliver the first FDA-approved therapies for rare skin diseases.

Raleigh-based Attindas Hygiene Partners acquires 53-year-old Italian firm SILC, a strategic move to capture a larger share of Europe's booming hygiene market.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

New research reveals a stark disconnect between clinical views and patient reality in atopic dermatitis, with millions suffering severe, overlooked impacts.

After two decades, Dr. Andrew Weil and daughter Diana unveil a modern, simplified Anti-Inflammatory Food Pyramid, launching a new digital health era.

A new survey shows no firm recovers from cyberattacks in a day, with downtime lasting weeks. Yet, executive focus on resilience may be dangerously waning.

After its successful 2025 IPO, CoastalSouth Bancshares celebrates its NYSE listing. Can the regional bank leverage Wall Street capital without losing its local focus?

FirstService Residential's upcoming trade show offers free, crucial training and vendor access to volunteer boards navigating complex laws and maintenance.

A new 'digital twin' platform from Kontakt.io promises to transform hospital operations by predicting patient needs and optimizing workflows in real time.

With its first drug approved and a deep pipeline, all eyes are on Nuvation Bio's CEO David Hung at the upcoming J.P. Morgan Healthcare Conference.

Harvard Pilgrim's annual Honor Roll names 34 top physician groups, using rigorous national data to guide patients to the highest quality of care.

With its lead asset TEC-001 targeting tough liver cancers, Teclison's presence at the ASCO GI Symposium puts its innovative approach in the spotlight.

Koddi unveils new AI to move marketers beyond dashboards, using conversational queries and automated budget optimization to supercharge campaign performance.

A $250M deal for re-performing auto loans reveals how specialized firms help major banks navigate complex regulations and optimize their balance sheets.

Main Street Capital realizes a massive gain from its Mystic Logistics exit and reinvests to merge it with UBM, creating a powerhouse in marketing mail.